Sumitomo Mitsui DS Asset Management Company Ltd Boosts Stock Holdings in Zoetis Inc. $ZTS

Sumitomo Mitsui DS Asset Management Company Ltd raised its holdings in Zoetis Inc. (NYSE:ZTS) by 19.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 113,621 shares of the company’s stock after purchasing an additional 18,837 shares during the quarter. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in Zoetis were worth $16,625,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Brighton Jones LLC lifted its holdings in shares of Zoetis by 180.4% in the 4th quarter. Brighton Jones LLC now owns 4,629 shares of the company’s stock valued at $754,000 after buying an additional 2,978 shares during the period. Empowered Funds LLC grew its holdings in Zoetis by 6.2% during the first quarter. Empowered Funds LLC now owns 11,293 shares of the company’s stock worth $1,859,000 after acquiring an additional 657 shares during the period. Woodline Partners LP raised its position in Zoetis by 120.6% in the first quarter. Woodline Partners LP now owns 37,832 shares of the company’s stock worth $6,229,000 after acquiring an additional 20,684 shares in the last quarter. Integrity Alliance LLC. purchased a new position in Zoetis in the first quarter worth $536,000. Finally, Intech Investment Management LLC lifted its holdings in Zoetis by 17.2% in the first quarter. Intech Investment Management LLC now owns 8,347 shares of the company’s stock valued at $1,374,000 after acquiring an additional 1,224 shares during the period. Institutional investors and hedge funds own 92.80% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on ZTS shares. Bank of America cut shares of Zoetis from a “buy” rating to a “neutral” rating and set a $135.00 price target on the stock. in a research note on Monday, December 15th. BTIG Research reaffirmed a “buy” rating and issued a $160.00 target price on shares of Zoetis in a report on Wednesday, December 3rd. Barclays started coverage on shares of Zoetis in a research report on Monday, December 8th. They set an “equal weight” rating and a $136.00 price target for the company. JPMorgan Chase & Co. lowered their price target on Zoetis from $230.00 to $200.00 and set an “overweight” rating on the stock in a report on Wednesday, November 5th. Finally, The Goldman Sachs Group raised Zoetis to a “buy” rating in a research note on Monday, December 15th. Six research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $160.18.

Zoetis Stock Up 0.2%

ZTS stock opened at $127.10 on Friday. The company has a debt-to-equity ratio of 1.31, a current ratio of 3.64 and a quick ratio of 2.28. The company’s 50 day simple moving average is $123.29 and its 200-day simple moving average is $140.60. Zoetis Inc. has a 12 month low of $115.25 and a 12 month high of $177.40. The firm has a market capitalization of $56.01 billion, a PE ratio of 21.40, a P/E/G ratio of 2.59 and a beta of 0.97.

Zoetis (NYSE:ZTS) last posted its earnings results on Tuesday, November 4th. The company reported $1.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.62 by $0.08. The firm had revenue of $2.40 billion for the quarter, compared to analyst estimates of $2.42 billion. Zoetis had a return on equity of 57.19% and a net margin of 28.21%.Zoetis’s revenue was up .5% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.58 EPS. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Equities analysts expect that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 3rd. Stockholders of record on Tuesday, January 20th will be given a $0.53 dividend. This is an increase from Zoetis’s previous quarterly dividend of $0.50. This represents a $2.12 annualized dividend and a dividend yield of 1.7%. The ex-dividend date is Tuesday, January 20th. Zoetis’s dividend payout ratio (DPR) is currently 33.67%.

Zoetis Company Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.